Healthcare provider profile · identity verified

Suman Prasad

Internal Medicine · DURHAM, NC · NPI 1760460349

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	368	73
Atorvastatin Calcium	Atorvastatin Calcium	317	67
Gabapentin	Gabapentin	269	61
Levothyroxine Sodium	Levothyroxine Sodium	261	56
Amlodipine Besylate	Amlodipine Besylate	218	48
Furosemide	Furosemide	217	55
Metoprolol Succinate	Metoprolol Succinate	204	39
Potassium Chloride	Potassium Chloride	172	33
Losartan Potassium	Losartan Potassium	115	23
Trazodone Hcl	Trazodone Hcl	107	48
Metoprolol Tartrate	Metoprolol Tartrate	104	27
Omeprazole	Omeprazole	103	23
Mirtazapine	Mirtazapine	101	34
Sertraline Hcl	Sertraline Hcl	95	26
Lisinopril	Lisinopril	94	23
Escitalopram Oxalate	Escitalopram Oxalate	88	22
Pantoprazole Sodium	Pantoprazole Sodium	86	37
Carbidopa-Levodopa	Carbidopa/Levodopa	83	11
Oxycodone Hcl	Oxycodone Hcl	83	58
Quetiapine Fumarate	Quetiapine Fumarate	83	30
Tamsulosin Hcl	Tamsulosin Hcl	77	20
Lorazepam	Lorazepam	72	29
Fluticasone Propionate	Fluticasone Propionate	68	26
Sodium Chloride	0.9 % Sodium Chloride	68	16
Tramadol Hcl	Tramadol Hcl	68	33
Xarelto	Rivaroxaban	62	suppressed
Duloxetine Hcl	Duloxetine Hcl	61	19
Midodrine Hcl	Midodrine Hcl	59	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	59	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	58	suppressed
Memantine Hcl	Memantine Hcl	58	11
Allopurinol	Allopurinol	57	suppressed
Carvedilol	Carvedilol	55	20
Simvastatin	Simvastatin	53	13
Jardiance	Empagliflozin	49	12
Alendronate Sodium	Alendronate Sodium	47	12
Latanoprost	Latanoprost	45	13
Hydrochlorothiazide	Hydrochlorothiazide	42	suppressed
Ondansetron Hcl	Ondansetron Hcl	42	32
Levetiracetam	Levetiracetam	41	14
Metformin Hcl	Metformin Hcl	41	11
Sodium Chloride	Sodium Chloride Irrig Solution	41	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	40	19
Torsemide	Torsemide	40	14
Clopidogrel	Clopidogrel Bisulfate	39	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	38	24
Dextrose In Water	Dextrose 5 % In Water	38	suppressed
Ezetimibe	Ezetimibe	38	12
Famotidine	Famotidine	38	11
Spironolactone	Spironolactone	38	suppressed
Olanzapine	Olanzapine	37	11
Baclofen	Baclofen	35	suppressed
Januvia	Sitagliptin Phosphate	35	suppressed
Amiodarone Hcl	Amiodarone Hcl	34	12
Ondansetron Odt	Ondansetron	34	15
Myrbetriq	Mirabegron	32	suppressed
Donepezil Hcl	Donepezil Hcl	31	11
Finasteride	Finasteride	31	suppressed
Farxiga	Dapagliflozin Propanediol	30	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Loperamide	Loperamide Hcl	30	19
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	29	15
Lansoprazole	Lansoprazole	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Prednisone	Prednisone	27	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Diltiazem Hcl	Diltiazem Hcl	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Hydrocortisone	Hydrocortisone	24	suppressed
Morphine Sulfate	Morphine Sulfate	24	22
Alprazolam	Alprazolam	23	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Estradiol	Estradiol	22	suppressed
Glimepiride	Glimepiride	21	suppressed
Valsartan	Valsartan	21	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	21	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	20	suppressed
Cephalexin	Cephalexin	20	15
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Anastrozole	Anastrozole	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	14
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	18	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	16	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	16	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Digoxin	Digoxin	14	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	14	12
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Budesonide	Budesonide	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Lacosamide	Lacosamide	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Victoza 3-Pak	Liraglutide	13	suppressed
Bromocriptine Mesylate	Bromocriptine Mesylate	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	11
Nystatin	Nystatin	11	suppressed
Pravastatin Sodium	Pravastatin Sodium	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error